Page last updated: 2024-11-06

floxuridine and Cancer, Second Primary

floxuridine has been researched along with Cancer, Second Primary in 2 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Research Excerpts

ExcerptRelevanceReference
"We report here a very rare case of chronic myeloid leukemia (CML) following long-term chemotherapy with 5'-deoxy-5-fluorouridine (5'-DFUR) for gastric cancer."2.44Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer. ( Emi, N; Ezaki, K; Handa, K; Hasegawa, A; Maruyama, F; Mizuta, S; Okamoto, M; Tsuzuki, M; Watanabe, M; Yamamoto, K; Yamamoto, Y, 2008)
"Postoperatively cecal cancer was detected."2.39[Peritoneal dissemination of cecal cancer disappearing in a patient taking 5'-DFUR for 3 years]. ( Etoh, T; Maeda, Y; Matoba, N; Nagata, T; Niiyama, H; Yoshida, J, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsuzuki, M1
Handa, K1
Yamamoto, K1
Hasegawa, A1
Yamamoto, Y1
Watanabe, M1
Mizuta, S1
Maruyama, F1
Okamoto, M1
Emi, N1
Ezaki, K1
Etoh, T1
Yoshida, J1
Matoba, N1
Niiyama, H1
Maeda, Y1
Nagata, T1

Reviews

2 reviews available for floxuridine and Cancer, Second Primary

ArticleYear
Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer.
    Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:19

    Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Floxuridine; Humans; Leukemia, Myelog

2008
[Peritoneal dissemination of cecal cancer disappearing in a patient taking 5'-DFUR for 3 years].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:5

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Cecal Neoplasms; Female; Floxuridine; Humans; Middle Ag

1994